EuroPCR: TAVI goliaths battle it out; Direct Flow impresses the docs
This article was originally published in Clinica
Executive Summary
Edwards Lifesciences’ presence at this year’s EuroPCR in Paris, France was overshadowed somewhat by its announcement earlier in the meeting that it has voluntarily paused the clinical program for its Fortis transcatheter mitral valve following reports of valve thrombosis.